Hepatitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subjects.
Condition: Chronic Hepatitis b Interventions: Drug: AB-101; Drug: Placebo; Drug: Nucleos(t)ide Analogue Sponsor: Arbutus Biopharma Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
Condition: Hepatitis B Interventions: Drug: DA-2803; Drug: DA-2803-R; Drug: Placebo of DA-2803; Drug: Placebo of DA-2803-R Sponsor: Dong-A ST Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2023 Category: Research Source Type: clinical trials

Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.
Conditions: Chronic Hepatitis B; Non-alcoholic Fatty Liver Disease Intervention: Other: exercise Sponsor: National Taiwan University Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2023 Category: Research Source Type: clinical trials